Saudi Arabia’s King Salman and Crown Prince congratulate interior minister on Eid Al-Adha

Saudi Arabia’s King Salman and Crown Prince congratulate interior minister on Eid Al-Adha
Saudi Arabia’s King Salman and Crown Prince Mohammed bin Salman sent cables to the Saudi Interior Minister Prince Abdul Aziz bin Saud bin Naif congratulating him on Eid Al-Adha. (SPA)
Updated 17 August 2019

Saudi Arabia’s King Salman and Crown Prince congratulate interior minister on Eid Al-Adha

Saudi Arabia’s King Salman and Crown Prince congratulate interior minister on Eid Al-Adha
  • Around 2.5 million pilgrims performed the Hajj this year
  • Eid Al-Adha, which is celebrated by Muslims across the world who are not performing Hajj, began on Sunday Aug. 11, 2019

RIYADH: Saudi Arabia’s King Salman and Crown Prince Mohammed bin Salman sent cables to the Saudi Interior Minister Prince Abdul Aziz bin Saud bin Naif congratulating him on Eid Al-Adha and the success of Hajj 2019.
They also thanked Prince Abdul Aziz bin Saud bin Naif for his cables congratulating them on the occasion of Eid Al-Adha.
Previously, the interior minister had thanked the king for taking care of Hajj pilgrims and for providing them with all the facilities and services that they needed.
Around 2.5 million pilgrims performed the Hajj this year and all the measures put in place by authorities and agencies were successful, he added.
Eid Al-Adha, which is celebrated by Muslims across the world who are not performing Hajj, began on Sunday Aug. 11, 2019.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 20 min 15 sec ago

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.